Announcements Trials

Browse Landscape

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Serotonin Syndrome 1 Neuroendocrine Tumors 1

Interventions

Surveys and Questionnaires 286 Blood Specimen Collection 145 Gene Expression Profiling 96 Interviews as Topic 83 Immunohistochemistry 78 Polymerase Chain Reaction 64 Surgical Procedures, Operative 62 Magnetic Resonance Spectroscopy 59 Microarray Analysis 55 Flow Cytometry 53 Radiotherapy 49 Amplified Fragment Length Polymorphism Analysis 48 Drug Therapy 46 Observation 45 Biopsy 42 Bevacizumab 40 Reverse Transcriptase Polymerase Chain Reaction 39 Data Collection 35 Sorafenib 29 Psychiatric Rehabilitation 29 Nivolumab 28 palbociclib 26 In Situ Hybridization, Fluorescence 26 Rituximab 25 Hepatectomy 25 Therapeutics 24 Neoadjuvant Therapy 24 Docetaxel 24 Colonoscopy 24 Sunitinib 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Observational × telotristat ethyl × Clear all

NCT03223428 2024-07-24

RELAX

TerSera Therapeutics LLC

223 enrolled 16 charts

Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡